Methylation of p15 INK4b and Expression of ANRIL on Chromosome 9p21 Are Associated with Coronary Artery Disease

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Zhuang, Jianhui ^a   Peng, Wenhui ^a   Li, Hailing ^a   Wang, Wei ^b   Wei, Yidong ^a   Li, Weiming ^a   Xu, Yawei ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANRIL LONG NON CODING RNA, HUMAN; ANRIL LONG NON-CODING RNA, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; LONG UNTRANSLATED RNA;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANRIL GENE; ARTICLE; BAX GENE; BCL 2 GENE; BINDING SITE; CELL ISOLATION; CHROMOSOME 9P; CHROMOSOME 9P21; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; EPIGENETICS; EXON; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HUMAN; INK4 ARF GENE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; P14 ARF GENE; P15 INK4B GENE; P16 INK4A GENE; PROMOTER REGION; PROTEIN DENATURATION; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; TIMP3 GENE; CHROMOSOME 9; GENE ORDER; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

AGED; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY DISEASE; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENE ORDER; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; RNA, LONG UNTRANSLATED;

EID: 84867623646     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047193     Document Type: Article

References (48)

1. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, et al. (2007) Replicating genotype-phenotype associations. Nature 447: 655-660.
2. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491.
3. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al. (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316: 1491-1493.
4. Welcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
5. Preuss M, Konig IR, Thompson JR, Erdmann J, Absher D, et al. (2010) Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet 3: 475-483.
6. Peng WH, Lu L, Zhang Q, Zhang RY, Wang LJ, et al. (2009) Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese. Clin Chem Lab Med 47: 917-922.
7. Silander K, Tang H, Myles S, Jakkula E, Timpson NJ, et al. (2009) Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. Genome Med 1: 51.
8. Zhou L, Zhang X, He M, Cheng L, Chen Y, et al. (2008) Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc Biol 28: 2085-2089.
9. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, et al. (2007) Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 67: 3963-3969.
10. Visel A, Zhu Y, May D, Afzal V, Gong E, et al. (2010) Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464: 409-412.
11. Congrains A, Kamide K, Oguro R, Yasuda O, Miyata K, et al. (2012) Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 220: 449-455.
12. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, et al. (2008) Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 17: 806-814.
13. Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, et al. (2010) Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet 6: e1001233.
14. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B, (2010) Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet 6: e1000899.
15. Holdt LM, Beutner F, Scholz M, Gielen S, Gabel G, et al. (2010) ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol 30: 620-627.
16. Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, et al. (2009) Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 29: 1671-1677.
17. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, et al. (2009) INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One 4: e5027.
18. Folkersen L, Kyriakou T, Goel A, Peden J, Malarstig A, et al. (2009) Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 4: e7677.
19. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, et al. (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38: 662-674.
20. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, et al. (2011) Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 30: 1956-1962.
21. Esteller M, (2008) Epigenetics in cancer. N Engl J Med 358: 1148-1159.
22. Ling C, Groop L, (2009) Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58: 2718-2725.
23. Ballestar E, (2011) Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol 7: 263-271.
24. Herman JG, Baylin SB, (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054.
25. Esteller M, (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427-5440.
26. Li HL, Peng WH, Cui ST, Lei H, Wei YD, et al. (2011) Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med 49: 1547-1554.
27. Zhong C, Qu X, Tan M, Meng YG, Ferrara N, (2009) Characterization and regulation of bv8 in human blood cells. Clin Cancer Res 15: 2675-2684.
28. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, et al. (2001) Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61: 3410-3418.
29. Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, et al. (2006) Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 8: 209-217.
30. Mitra S, Khaidakov M, Lu J, Ayyadevara S, Szwedo J, et al. (2011) Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation. Am J Physiol Heart Circ Physiol 301: H506-513.
31. Ordovas JM, Smith CE, (2010) Epigenetics and cardiovascular disease. Nat Rev Cardiol 7: 510-519.
32. Kim M, Long TI, Arakawa K, Wang R, Yu MC, et al. (2010) DNA methylation as a biomarker for cardiovascular disease risk. PLoS One 5: e9692.
33. Nanayakkara PW, Kiefte-de Jong JC, Stehouwer CD, van Ittersum FJ, Olthof MR, et al. (2008) Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease. Nephrol Dial Transplant 23: 2586-2592.
34. Sharma P, Kumar J, Garg G, Kumar A, Patowary A, et al. (2008) Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol 27: 357-365.
35. Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, et al. (2007) Impact of inflammation on epigenetic DNA methylation- a novel risk factor for cardiovascular disease? J Intern Med 261: 488-499.
36. Gil J, Peters G, (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7: 667-677.
37. Makar KW, Wilson CB, (2004) DNA methylation is a nonredundant repressor of the Th2 effector program. J Immunol 173: 4402-4406.
38. Baccarelli A, Rienstra M, Benjamin EJ, (2010) Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ Cardiovasc Genet 3: 567-573.
39. Kuo CL, Murphy AJ, Sayers S, Li R, Yvan-Charvet L, et al. (2011) Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation. Arterioscler Thromb Vasc Biol 31: 2483-2492.
40. Gonzalez-Navarro H, Abu Nabah YN, Vinue A, Andres-Manzano MJ, Collado M, et al. (2010) p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis. J Am Coll Cardiol 55: 2258-2268.
41. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, et al. (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451: 202-206.
42. Gibb EA, Brown CJ, Lam WL, (2011) The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10: 38.
43. Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, et al. (2003) Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 34: 157-165.
44. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, et al. (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874.
45. Reynolds PA, Sigaroudinia M, Zardo G, Wilson MB, Benton GM, et al. (2006) Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J Biol Chem 281: 24790-24802.
46. Mohammad HP, Cai Y, McGarvey KM, Easwaran H, Van Neste L, et al. (2009) Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Res 69: 6322-6330.
47. Paul TA, Bies J, Small D, Wolff L, (2010) Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. Blood 115: 3098-3108.
48. Holdt LM, Teupser D, (2012) Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol 32: 196-206.